title: Taxol plus gemcitabine and vinorelbine given every other week in advanced chemo-naïve non-small cell lung cancer patients.
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Frasci
authors.forename: Pasquale
authors.initials: P
authors.lastname: Comella
authors.forename: Giuseppe
authors.initials: G
authors.lastname: De Cataldis
authors.forename: Luigi
authors.initials: L
authors.lastname: Maiorino
authors.forename: Francesco
authors.initials: F
authors.lastname: Fiore
authors.forename: Vincenzo
authors.initials: V
authors.lastname: De Rosa
authors.forename: Liliana
authors.initials: L
authors.lastname: Lapenta
authors.forename: Marina
authors.initials: M
authors.lastname: Licenziato
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Comella
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007558:Italy; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D017239:Paclitaxel / Q000008:administration & dosage; D016896:Treatment Outcome; D014747:Vinblastine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D000077235:Vinorelbine; D000093542:Gemcitabine
chemical_list: D003841:Deoxycytidine; D014747:Vinblastine; D017239:Paclitaxel; D000077235:Vinorelbine; D000093542:Gemcitabine